160
Views
28
CrossRef citations to date
0
Altmetric
Review

Vector-mediated drug delivery to the brain

, , &
Pages 773-782 | Published online: 23 Feb 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Yao Qin, Qianyu Zhang, Huali Chen, Wenmin Yuan, Rui Kuai, Fulan Xie, Li Zhang, Xiaoxiao Wang, Zhirong Zhang, Ji Liu & Qin He. (2012) Comparison of four different peptides to enhance accumulation of liposomes into the brain. Journal of Drug Targeting 20:3, pages 235-245.
Read now
Richard T. Carroll, Deepak Bhatia, Werner Geldenhuys, Ruchi Bhatia, Nicholas Miladore, Anupam Bishayee & Vijaykumar Sutariya. (2010) Brain-targeted delivery of Tempol-loaded nanoparticles for neurological disorders. Journal of Drug Targeting 18:9, pages 665-674.
Read now
Kavitha S Rao, Anuja Ghorpade & Vinod Labhasetwar. (2009) Targeting anti-HIV drugs to the CNS. Expert Opinion on Drug Delivery 6:8, pages 771-784.
Read now

Articles from other publishers (25)

Nikhil Bhavsar, Bhagawati Saxena & Jigna Shah. 2022. Nanocarriers for Drug-Targeting Brain Tumors. Nanocarriers for Drug-Targeting Brain Tumors 31 48 .
Afrasim Moin, Syed Mohd Danish Rizvi, Talib Hussain, D. V. Gowda, Gehad M. Subaiea, Mustafa M. A. Elsayed, Mukhtar Ansari, Abulrahman Sattam Alanazi & Hemant Yadav. (2021) Current Status of Brain Tumor in the Kingdom of Saudi Arabia and Application of Nanobiotechnology for Its Treatment: A Comprehensive Review. Life 11:5, pages 421.
Crossref
Mei Mei Tian & Reinhard Gabathuler. 2021. Nanomedicines for Brain Drug Delivery. Nanomedicines for Brain Drug Delivery 119 147 .
P Siahaan, N E Darmastuti, S Aisyafalah, N A Sasongko, D Hudiyanti, M Asy’ari & V D Prasasty. (2020) Probing the interaction between EC1-EC2 domain of E-cadherin with conformational structure of cyclic ADTC7 (Ac-CDTPDC-NH 2 ) peptide using molecular docking approach . Journal of Physics: Conference Series 1524, pages 012081.
Crossref
Edward Helal-Neto, Aline Oliveira da Silva de Barros, Roberta Saldanha-Gama, Renata Brandão-Costa, Luciana Magalhães Rebêlo Alencar, Clenilton Costa dos Santos, Ramón Martínez-Máñez, Eduardo Ricci-Junior, Frank Alexis, Verônica Morandi, Christina Barja-Fidalgo & Ralph Santos-Oliveira. (2019) Molecular and Cellular Risk Assessment of Healthy Human Cells and Cancer Human Cells Exposed to Nanoparticles. International Journal of Molecular Sciences 21:1, pages 230.
Crossref
Somaye Ghasemy, Júlia García-Pindado, Fatemeh Aboutalebi, Kianoush Dormiani, Meritxell Teixidó & Morteza Malakoutikhah. (2018) Fine-tuning the physicochemical properties of peptide-based blood–brain barrier shuttles. Bioorganic & Medicinal Chemistry 26:8, pages 2099-2106.
Crossref
Itsaso Cabezón, Elisabet Augé, Manel Bosch, Alison J. Beckett, Ian A. Prior, Carme Pelegrí & Jordi Vilaplana. (2017) Serial block-face scanning electron microscopy applied to study the trafficking of 8D3-coated gold nanoparticles at the blood–brain barrier. Histochemistry and Cell Biology 148:1, pages 3-12.
Crossref
Vera Neves, Frederico Aires-da-Silva, Maurício Morais, Lurdes Gano, Elisabete Ribeiro, Antónia Pinto, Sandra Aguiar, Diana Gaspar, Célia Fernandes, João D. G. Correia & Miguel A. R. B. Castanho. (2017) Novel Peptides Derived from Dengue Virus Capsid Protein Translocate Reversibly the Blood–Brain Barrier through a Receptor-Free Mechanism. ACS Chemical Biology 12:5, pages 1257-1268.
Crossref
K. K. Pulicherla & Mahendra Kumar Verma. (2015) Targeting Therapeutics Across the Blood Brain Barrier (BBB), Prerequisite Towards Thrombolytic Therapy for Cerebrovascular Disorders—an Overview and Advancements. AAPS PharmSciTech 16:2, pages 223-233.
Crossref
Reinhard Gabathuler. 2014. Drug Delivery to the Brain. Drug Delivery to the Brain 455 484 .
Chang-lin Wang, Chao Guo, Yi-qing Wang, Ying Zhou, Qian Li, Jing-man Ni & Rui Wang. (2011) Synthesis and antinociceptive effects of endomorphin-1 analogs with C-terminal linked by oligoarginine. Peptides 32:2, pages 293-299.
Crossref
Reinhard Gabathuler. (2010) Development of new peptide vectors for the transport of therapeutic across the blood–brain barrier. Therapeutic Delivery 1:4, pages 571-586.
Crossref
Serguei V Vinogradov, Larisa Y Poluektova, Edward Makarov, Trevor Gerson & Madapathage T Senanayake. (2010) Nano-NRTIs: Efficient Inhibitors of HIV Type-1 in Macrophages with a Reduced Mitochondrial Toxicity. Antiviral Chemistry and Chemotherapy 21:1, pages 1-14.
Crossref
Reinhard Gabathuler. (2010) Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases. Neurobiology of Disease 37:1, pages 48-57.
Crossref
S. V. Sarantseva, O. I. Bolshakova, S. I. Timoshenko, A. A. Kolobov, M. P. Vitek & A. L. Schwarzman. (2009) Protein transduction domain peptide mediates delivery to the brain via the blood-brain barrier in Drosophila melanogaster. Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry 3:2, pages 149-155.
Crossref
Delara Karkan, Cheryl Pfeifer, Timothy Z. Vitalis, Gavin Arthur, Maki Ujiie, Qingqi Chen, Sam Tsai, Gerrasimo Koliatis, Reinhard Gabathuler & Wilfred A. Jefferies. (2008) A Unique Carrier for Delivery of Therapeutic Compounds beyond the Blood-Brain Barrier. PLoS ONE 3:6, pages e2469.
Crossref
Mary F. Dempsey, David Wyper, Jonathan Owens, Sally Pimlott, Vakis Papanastassiou, James Patterson, Donald M. Hadley, Alice Nicol, Roy Rampling & S.M. Brown. (2006) Assessment of 123I-FIAU imaging of herpes simplex viral gene expression in the treatment of glioma. Nuclear Medicine Communications 27:8, pages 611-617.
Crossref
Robin Polt, Muthu Dhanasekaran & Charles M. Keyari. (2005) Glycosylated neuropeptides: A new vista for neuropsychopharmacology?. Medicinal Research Reviews 25:5, pages 557-585.
Crossref
Jamal Temsamani, Cécile Bonnafous, Christophe Rousselle, Yannik Fraisse, Philippe Clair, Luc-André Granier, Anthony R. Rees, Michel Kaczorek & Jean-Michel Scherrmann. (2005) Improved Brain Uptake and Pharmacological Activity Profile of Morphine-6-Glucuronide Using a Peptide Vector-Mediated Strategy. Journal of Pharmacology and Experimental Therapeutics 313:2, pages 712-719.
Crossref
Jamal Temsamani & Pierre Vidal. (2004) The use of cell-penetrating peptides for drug delivery. Drug Discovery Today 9:23, pages 1012-1019.
Crossref
Gang Liu, Ping Men, George Perry & Mark A. Smith. 2007. Nanotechnologies for the Life Sciences. Nanotechnologies for the Life Sciences.
R. Pawar, A. Avramoff & A. J. Domb. 2007. Nanotechnologies for the Life Sciences. Nanotechnologies for the Life Sciences.
Jamal Temsamani & Jean-Michel Scherrmann. 2003. Peptide Transport and Delivery into the Central Nervous System. Peptide Transport and Delivery into the Central Nervous System 221 238 .
Guillaume Drin, Christophe Rousselle, Jean-Michel Scherrmann, Anthony R Rees & Jamal Temsamani. (2015) Peptide delivery to the brain via adsorptive-mediated endocytosis: Advances with SynB vectors. AAPS PharmSci 4:4, pages 61-67.
Crossref
J.-M Scherrmann. (2002) Drug delivery to brain via the blood–brain barrier. Vascular Pharmacology 38:6, pages 349-354.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.